Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | ATM | Q13315 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8707677 | 0.90 | ALDH1A1 (0.55) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL30158125 | 0.90 | ALDH1A1 (0.55) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL8562232 | 0.85 | ALDH1A1 (0.52) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL16573482 | 0.84 | ALDH1A1 (0.52) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL7029313 | 0.83 | MEN1 (0.49) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL16573485 | 0.76 | MEN1 (0.48) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL21615668 | 0.74 | KMT2A (0.60) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL411971 | 0.73 | ALDH1A1 (0.57) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL12651748 | 0.73 | MEN1 (0.74) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL8592677 | 0.72 | ALDH1A1 (0.77) | ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0802788-A4 | NOVEL THERAPEUTIC DELIVERY SYSTEMS | UNGER EVAN C (US) | 1998-09-09 | — | — | EP | claimed |
| EP-0712293-A4 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0802788-A1 | NOVEL THERAPEUTIC DELIVERY SYSTEMS | UNGER, Evan C (US) | 1997-10-29 | — | — | EP | claimed |
| EP-0712293-A1 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER, Evan C (US) | 1996-05-22 | — | — | EP | claimed |
| WO-1994028780-A2 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994028874-A1 | NOVEL THERAPEUTIC DELIVERY SYSTEMS | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |
| US-20250195621-A1 | SYNTHETIC PLATELETS | UNIV CASE WESTERN RESERVE (US) | 2025-06-19 | — | — | US | disclosed |
| US-20190247526-A1 | Microbubble Compositions, Method of Making Same, and Method Using Same | Microvascular Therapeutics LLC | 2019-08-15 | — | — | US | disclosed |
| US-10279053-B2 | Microbubble compositions, method of making same, and method using same | NUVOX PHARMA LLC (US) | 2019-05-07 | — | — | US | disclosed |
| WO-2013013067-A2 | MICROBUBBLE COMPOSITIONS, METHOD OF MAKING SAME, AND METHOD USING SAME | NUVOX PHARMA, L.L.C. (US) | 2013-01-24 | — | — | WO | disclosed |
| US-20130022550-A1 | Microbubble Compositions, Method of Making Same, and Method Using Same | Microvascular Therapeutics LLC | 2013-01-24 | — | — | US | disclosed |
| WO-2012142362-A2 | SYNTHETIC PLATELETS | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-10-18 | — | — | WO | disclosed |
| EP-1337278-A2 | SIMULTANEOUS IMAGING OF CARDIAC PERFUSION AND A VITRONECTIN RECEPTOR TARGETED IMAGING AGENT | Bristol-Myers Squibb Medical Imaging, Inc. (US) | 2003-08-27 | — | — | EP | disclosed |
| US-6548047-B1 | Using lecithin, cephalin filled with gases; scanning; medical diagnosis | BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC. | 2003-04-15 | — | — | US | disclosed |
| WO-2002055111-A2 | SIMULTANEOUS IMAGING OF CARDIAC PERFUSION AND A VITRONECTIN RECEPTOR TARGETED IMAGING AGENT | BRISTOL MYERS SQUIBB MEDICAL I (US) | 2002-07-18 | — | — | WO | disclosed |
| US-5830430-A | Cationic lipids and the use thereof | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130022550-A1 | Microbubble Compositions, Method of Making Same, and Method Using Same | SHH, GLI1, SON | ALDH1A1 3850/4885HPGD 4283/4885SMN1; SMN2 2109/4885 |
| US-20190247526-A1 | Microbubble Compositions, Method of Making Same, and Method Using Same | SHH, GLI1, SON | ALDH1A1 3850/4885HPGD 4283/4885SMN1; SMN2 2109/4885 |
| US-10279053-B2 | Microbubble compositions, method of making same, and method using same | SHH, GLI1, SON | ALDH1A1 3850/4885HPGD 4283/4885SMN1; SMN2 2109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.